US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cocrystal Pharma, Inc.

1.71

-0.2310-11.91%

Volume:182.27K

Turnover:324.24K

Market Cap:17.39M

PE:-1.10

High:1.90

Open:1.85

Low:1.70

Close:1.94

Loading ...

Overview Company News Filings

Cocrystal Pharma Inc. Announces Phase 1 Study Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference

Cocrystal Pharma Inc. Unveils Presentation on Oral Pan-Viral Protease Inhibitor for Norovirus and Coronavirus Prevention and Treatment

Cocrystal Pharma Inc. Unveils Investor Presentation Highlighting Innovative Antiviral Drug Development Programs

Cocrystal Pharma Inc. Concluded Annual Stockholders Meeting

Cocrystal Pharma Is Maintained at Buy by HC Wainwright & Co.

Cocrystal Pharma Amends Bylaws to Adjust Quorum Requirements

Cocrystal Pharma Inc. Unveils Investor Presentation Highlighting Innovative Antiviral Drug Development Programs

BRIEF-Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency Against 2024 H5n1 Avian Influenza Strain

Cocrystal Pharma (COCP) Gets a Buy from Noble Financial

Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Cocrystal Pharma Q1 EPS $(0.23) Beats $(0.51) Estimate

BRIEF-Cocrystal Pharma Q1 Net Income USD -2.301 Million

Cocrystal Pharma Inc expected to post a loss of 50 cents a share - Earnings Preview

Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

COCP: Norovirus Challenge Study Planned for 2025…

Zacks Small Cap Research

BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million

Cocrystal Pharma Inc expected to post a loss of 53 cents a share - Earnings Preview

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Cocrystal Pharma And 2 Other Promising US Penny Stocks To Watch

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COCP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COCP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCP\",,,,,undefined,":{"symbol":"COCP","market":"US","secType":"STK","nameCN":"Cocrystal Pharma, Inc.","latestPrice":1.709,"timestamp":1754421090968,"preClose":1.94,"halted":0,"volume":182271,"delay":0,"floatShares":6554726,"shares":10173790,"eps":-1.557794,"marketStatus":"Trading","change":-0.231,"latestTime":"08-05 15:18:28 EDT","open":1.85,"high":1.9,"low":1.7,"amount":324236.8876746,"amplitude":0.103093,"askPrice":1.71,"askSize":71,"bidPrice":1.66,"bidSize":15,"shortable":0,"etf":0,"ttmEps":-1.557794,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1754424000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.94,"preHourTrading":{"tag":"盘前","latestPrice":1.84,"preClose":1.94,"latestTime":"09:24 EDT","volume":13872,"amount":25429.7009472,"timestamp":1754400256909},"postHourTrading":{"tag":"盘后","latestPrice":1.83,"preClose":1.94,"latestTime":"19:53 EDT","volume":18168,"amount":34042.9134,"timestamp":1754351606257},"volumeRatio":0.372215},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCP\",,,,,undefined,":{"symbol":"COCP","floatShares":6554726,"roa":"-53.96%","roe":"-106.05%","lyrEps":-1.720463,"volumeRatio":0.372215,"shares":10173790,"dividePrice":0,"high":1.9,"amplitude":0.103093,"preClose":1.94,"low":1.7,"week52Low":1.12,"pbRate":"2.38","week52High":3.26,"institutionHeld":0,"latestPrice":1.709,"committee":-0.651163,"eps":-1.557794,"divideRate":0,"volume":182271,"delay":0,"ttmEps":-1.557794,"open":1.85,"prevYearClose":2.02,"prevWeekClose":1.85,"prevMonthClose":1.73,"prevQuarterClose":1.49,"fiveDayClose":1.7392,"twentyDayClose":1.52,"sixtyDayClose":1.5682},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COCP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557301391","title":"Cocrystal Pharma Inc. Announces Phase 1 Study Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301391","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557301391?lang=en_us&edition=fundamental","pubTime":"2025-08-05 20:32","pubTimestamp":1754397137,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc. Announces Phase 1 Study Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL2S42yX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2557339911","title":"Cocrystal Pharma Inc. Unveils Presentation on Oral Pan-Viral Protease Inhibitor for Norovirus and Coronavirus Prevention and Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2557339911","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557339911?lang=en_us&edition=fundamental","pubTime":"2025-08-05 20:10","pubTimestamp":1754395830,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc. Unveils Presentation on Oral Pan-Viral Protease Inhibitor for Norovirus and Coronavirus Prevention and Treatment. Cocrystal Pharma Inc. has presented findings on an oral pan-viral protease inhibitor aimed at preventing and treating Norovirus and Coronavirus infections. The presentation, delivered by Dr. Sam Lee at the 2025 Military Health System Research Symposium, highlights the mechanism of action and results from a Phase 1 study of the inhibitor. This development is part of Cocrystal Pharma's broader effort to advance programs in direct-acting small molecule antivirals, targeting various viruses including Norovirus, Influenza, Coronavirus, and other respiratory viruses. The company utilizes its proprietary drug discovery platform technology, developed with Nobel Prize-winning technology, to potentially reduce development timelines and costs for novel drug candidates. You can access the full presentation through the link below.Disclaimer: This news brief was cre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL3gy83s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2554479432","title":"Cocrystal Pharma Inc. Unveils Investor Presentation Highlighting Innovative Antiviral Drug Development Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2554479432","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554479432?lang=en_us&edition=fundamental","pubTime":"2025-07-26 03:55","pubTimestamp":1753473308,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief on July 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL2jFt0c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2548588730","title":"Cocrystal Pharma Inc. Concluded Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2548588730","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548588730?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:31","pubTimestamp":1751401882,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc. held its 2025 Annual Meeting of Stockholders on June 25, 2025. During the meeting, stockholders voted on several key proposals. The election of six members to the Board of Directors was approved. The appointment of Weinberg & Company as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, the 2025 Equity Incentive Plan received approval. An adjournment proposal was rendered moot as all prior proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Secur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL6HCvJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2544012197","title":"Cocrystal Pharma Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2544012197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544012197?lang=en_us&edition=fundamental","pubTime":"2025-06-20 19:27","pubTimestamp":1750418820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COCP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 20, 2025 07:27 ET (11:27 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP"],"gpt_icon":0},{"id":"2544900487","title":"Cocrystal Pharma Amends Bylaws to Adjust Quorum Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2544900487","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544900487?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:02","pubTimestamp":1750276949,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc. has announced an amendment to its Amended and Restated Bylaws, as approved by the Board of Directors on June 17, 2025. The amendment changes the quorum requirement for stockholder meetings, stipulating that one third of the aggregate voting power of outstanding voting shares, represented in person or by proxy, will now constitute a quorum.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL5NVmjS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2544999301","title":"Cocrystal Pharma Inc. Unveils Investor Presentation Highlighting Innovative Antiviral Drug Development Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2544999301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544999301?lang=en_us&edition=fundamental","pubTime":"2025-06-17 23:34","pubTimestamp":1750174458,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc. has released an investor presentation detailing its advancements in developing potent antivirals targeting serious diseases, including influenza, norovirus, and coronavirus. The company utilizes a proprietary drug discovery platform developed with Nobel Prize-winning technology to create broad-spectrum antiviral drugs. Current programs include an oral influenza PB2 inhibitor , progressing in Phase 2a studies, and a dual oral norovirus and coronavirus protease inhibitor , which has completed Phase 1 studies. Cocrystal Pharma is also exploring collaboration opportunities for pandemic preparedness and is led by a seasoned team including Nobel laureates. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL3kYBmv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2539250299","title":"BRIEF-Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency Against 2024 H5n1 Avian Influenza Strain","url":"https://stock-news.laohu8.com/highlight/detail?id=2539250299","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539250299?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:28","pubTimestamp":1748521729,"startTime":"0","endTime":"0","summary":"BRIEF-Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency Against 2024 H5n1 Avian Influenza StrainMay 29 (Reuters) - Cocrystal Pharma Inc COCP.O:COCRYSTAL PHARMA’S INVESTIGATIONAL DRUG CANDIDAT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nFWN3S10SU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2536870466","title":"Cocrystal Pharma (COCP) Gets a Buy from Noble Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2536870466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536870466?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:35","pubTimestamp":1747661714,"startTime":"0","endTime":"0","summary":"Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Cocrystal Pharma (COCP – Research Report) today and set a price target of $10.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cocrystal-pharma-cocp-gets-a-buy-from-noble-financial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cocrystal-pharma-cocp-gets-a-buy-from-noble-financial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COCP","BK4007","NBL"],"gpt_icon":0},{"id":"2535084001","title":"Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535084001","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535084001?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:51","pubTimestamp":1747313506,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings SummaryCocrystal Pharma Inc COCP.OQ reported a quarterly adjusted loss of 23 cents per share for the quarter ended March ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL8N3RN1G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP"],"gpt_icon":0},{"id":"2535684275","title":"Cocrystal Pharma Q1 EPS $(0.23) Beats $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535684275","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535684275?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:18","pubTimestamp":1747311515,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.51) by 54.9 percent. This is a 41.03 percent increase over losses of $(0.39) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45434822/cocrystal-pharma-q1-eps-0-23-beats-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP"],"gpt_icon":0},{"id":"2535684418","title":"BRIEF-Cocrystal Pharma Q1 Net Income USD -2.301 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535684418","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535684418?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:00","pubTimestamp":1747310448,"startTime":"0","endTime":"0","summary":"BRIEF-Cocrystal Pharma Q1 Net Income USD -2.301 Million\n\n\nMay 15 (Reuters) - Cocrystal Pharma Q1 operating income USD -2.341 million.\n\nQ1 basic EPS USD -0.23\nQ1 operating expenses USD 2.341 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLXE6773F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2534433043","title":"Cocrystal Pharma Inc  expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534433043","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534433043?lang=en_us&edition=fundamental","pubTime":"2025-05-09 22:21","pubTimestamp":1746800481,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc  expected to post a loss of50cents a share - Earnings Preview Cocrystal Pharma Inc COCP.OQ COCP.O is expected to show no change in quarterly revenue when it reports  results on Ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH26D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP"],"gpt_icon":0},{"id":"2529937996","title":"Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants","url":"https://stock-news.laohu8.com/highlight/detail?id=2529937996","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529937996?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"Norovirus GII.17 variants have overtaken GII.4 as the most prevalent strain and significantly increased norovirus outbreaks in the U.S. and European countries in 2024-2025. Cocrystal Pharma’s pan-viral protease inhibitor CDI-988 shows superior broad-spectrum antiviral activity against major norovirus variants including GII.4 and GII.17 strains. Pan-Viral Inhibitor CDI-988 CDI-988 is a protease inhibitor specifically designed and developed as a broad-spectrum antiviral inhibitor to a highly conserved region in the active site of 3CL viral proteases. Based on a novel mechanism of action and superior broad-spectrum antiviral activity, CDI-988 is a compelling candidate for advancement as a first-in-class oral treatment for both noroviruses and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-norovirus-oral-antiviral-120000040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2527042247","title":"Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2527042247","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527042247?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:00","pubTimestamp":1744804800,"startTime":"0","endTime":"0","summary":"BOTHELL, Wash., April 16, 2025  -- Cocrystal Pharma, Inc.  announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest  2025 Conference on Wednesday, April 23, 2025 at 3:00 p.m. Pacific time. The conference is being held April 23-24 at the Seattle Convention Center.Life Science Innovation Northwest  is the Pacific Northwest’s largest annual life science conference. This event brings together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. Bringing together over 700 attendees, LSINW features 80+ company and research institution presentations, keynote addresses from industry leaders, engaging panel discussions on emerging trends, a dynamic startup fast pitch showdown, insightful poster presentations, and more - making it the must-attend event for the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-present-life-science-120000093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2524128771","title":"COCP: Norovirus Challenge Study Planned for 2025…","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128771","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128771?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:15","pubTimestamp":1743516900,"startTime":"0","endTime":"0","summary":"On January 8, 2025, Cocrystal Pharma, Inc.  announced results from the Phase 1 trial of CDI-988 for the prophylaxis and treatment of norovirus, coronavirus, and other viral infections. The results showed the drug had a favorable safety and tolerability profile for dosing up to 800 mg per day for 10 consecutive days. The company also announced that an additional cohort that will receive a dose of 1,200 mg and a shorter treatment duration of five consecutive days and we anticipate those results in the second quarter of 2025. In addition, Cocrystal is planning to initiate a human challenge study in norovirus-infected individuals to evaluate CDI-988 as a treatment and prophylaxis later in 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocp-norovirus-challenge-study-planned-141500542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","PK","CDC","COCP","BK4181","BK4218"],"gpt_icon":0},{"id":"2523945510","title":"BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2523945510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523945510?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422445,"startTime":"0","endTime":"0","summary":"BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million\n\n\nMar 31 (Reuters) - Cocrystal Pharma FY operating income USD -17.878 million.\n\nFY basic EPS USD -1.72\nFY operating expenses USD 17.878 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLXF33F87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2521723314","title":"Cocrystal Pharma Inc  expected to post a loss of 53 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521723314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521723314?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:33","pubTimestamp":1742819587,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc  expected to post a loss of53cents a share - Earnings Preview Cocrystal Pharma Inc COCP.OQ COCP.O is expected to show no change in quarterly revenue when it reports  results on Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q70XP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP"],"gpt_icon":0},{"id":"2519806034","title":"Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806034","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806034?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:35","pubTimestamp":1741955700,"startTime":"0","endTime":"0","summary":"NEW YORK, March 14, 2025  -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum, held March 13th are now available for online viewing.The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may downloadinvestor materials from the company’s resource section.Select companies are accepting 1x1 management meeting requests through March 18th.Virtual Investor Conferences  is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance thei","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/life-science-virtual-investor-forum-123500525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TELIF","TSYW.SI","AVCNF","USAW.SI","PDSB","QLD","TQQQ","CGTX","QID","NVIW.SI","PSQ",".IXIC","LADX","BK4179","COCP","FBLG","BK4007","MNQmain","HMTXF","NQmain","BK4139","IZOZF","USJW.SI","NGENF","SQQQ","FET","TNXP"],"gpt_icon":1},{"id":"2510354551","title":"Cocrystal Pharma And 2 Other Promising US Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2510354551","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510354551?lang=en_us&edition=fundamental","pubTime":"2025-02-12 04:11","pubTimestamp":1739304691,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates through a landscape marked by tariff discussions and Federal Reserve policy updates, investors are keeping a close eye on how these factors influence broader indices like the Dow Jones, S&P 500, and Nasdaq. Penny stocks may be a throwback term, but the opportunities they represent are far from old news. Typically referring to smaller or newer companies, these stocks present an underappreciated chance for growth at lower price points. When combined with strong balance sheets and solid fundamentals, they can offer upside without many of the risks often associated with this corner of the market.Overview: Cocrystal Pharma, Inc. is a biotechnology company dedicated to discovering and developing antiviral therapeutic treatments for serious and chronic viral diseases, with a market cap of $18.62 million.Operations: Cocrystal Pharma, Inc. currently does not report any revenue segments.Click to explore a detailed breakdown of our findings in Cocrystal Pharma's","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-2-other-promising-201131719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","COCP","BK4007","BK4209","BK4213","TOUR","PVL","BK4021","SB","KNDI","BK4563","BK4142"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COCP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"COCP","fiscalQuarterEnding":"2025/03","expectedEps":-0.52,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2025-03-31","symbol":"COCP","fiscalQuarterEnding":"2024/12","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-11-13","symbol":"COCP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.49},{"market":"US","date":"2024-08-14","symbol":"COCP","fiscalQuarterEnding":"2024/06","expectedEps":-0.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-13","symbol":"COCP","fiscalQuarterEnding":"2024/03","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"pre","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COCP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COCP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1616299200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COCP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COCP","date":"2025-08-04","current":-1.187552,"percent":0.434534,"low":-15.852314,"twenty":-4.145815,"median":-1.08799,"eighty":-0.815863,"high":-0.381225,"avg":-2.745135,"sd":3.27876,"marketCap":18821511},"quantilePoints":[{"date":"2020-08-07","current":-1.930085,"twenty":-9.125582,"median":-1.583731,"eighty":228.475593,"marketCap":106367009},{"date":"2020-08-14","current":-1.816551,"twenty":-8.999358,"median":-1.583731,"eighty":228.475593,"marketCap":100110129},{"date":"2020-08-21","current":-1.551637,"twenty":-8.999358,"median":-1.611206,"eighty":219.876516,"marketCap":85510732},{"date":"2020-08-28","current":-1.277663,"twenty":-8.999358,"median":-1.611206,"eighty":217.161993,"marketCap":70411994},{"date":"2020-09-04","current":-1.09662,"twenty":-8.999358,"median":-1.611206,"eighty":217.161993,"marketCap":60434746},{"date":"2020-09-11","current":-1.096861,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":60448031},{"date":"2020-09-18","current":-1.205342,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":66426406},{"date":"2020-09-25","current":-1.108915,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":61112295},{"date":"2020-10-02","current":-1.088545,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":59989689},{"date":"2020-10-09","current":-1.122776,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":61876198},{"date":"2020-10-16","current":-1.086013,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":59850194},{"date":"2020-10-23","current":-1.036715,"twenty":-8.999358,"median":-1.611206,"eighty":212.612857,"marketCap":57133355},{"date":"2020-10-30","current":-1.005617,"twenty":-8.999358,"median":-1.611206,"eighty":211.043611,"marketCap":55419554},{"date":"2020-11-06","current":-1.043103,"twenty":-8.999358,"median":-1.611206,"eighty":211.043611,"marketCap":57485414},{"date":"2020-11-13","current":-1.064204,"twenty":-8.999358,"median":-1.611206,"eighty":211.043611,"marketCap":59595396},{"date":"2020-11-20","current":-1.088446,"twenty":-8.999358,"median":-1.611206,"eighty":201.138046,"marketCap":60952953},{"date":"2020-11-27","current":-2.314018,"twenty":-8.999358,"median":-1.617511,"eighty":195.75877,"marketCap":129585021},{"date":"2020-12-04","current":-2.032418,"twenty":-8.999358,"median":-1.617511,"eighty":190.614749,"marketCap":113815410},{"date":"2020-12-11","current":-1.89774,"twenty":-8.999358,"median":-1.623615,"eighty":179.617525,"marketCap":106273427},{"date":"2020-12-18","current":-1.885496,"twenty":-8.999358,"median":-1.638904,"eighty":170.629154,"marketCap":105587793},{"date":"2020-12-24","current":-1.89774,"twenty":-8.999358,"median":-1.647648,"eighty":164.932031,"marketCap":106273427},{"date":"2020-12-31","current":-1.665114,"twenty":-8.999358,"median":-1.65475,"eighty":148.457852,"marketCap":93246361},{"date":"2021-01-08","current":-1.750818,"twenty":-8.999358,"median":-1.658661,"eighty":141.866387,"marketCap":98045804},{"date":"2021-01-15","current":-1.848766,"twenty":-8.999358,"median":-1.663294,"eighty":-0.323292,"marketCap":103530888},{"date":"2021-01-22","current":-2.583375,"twenty":-8.999358,"median":-1.668954,"eighty":-0.345906,"marketCap":144668991},{"date":"2021-01-29","current":-2.105879,"twenty":-8.999358,"median":-1.678549,"eighty":-0.362957,"marketCap":117929224},{"date":"2021-02-05","current":-2.436453,"twenty":-8.999358,"median":-1.678549,"eighty":-0.370474,"marketCap":136441368},{"date":"2021-02-12","current":-2.485427,"twenty":-8.999358,"median":-1.685858,"eighty":-0.380575,"marketCap":139183907},{"date":"2021-02-19","current":-2.362992,"twenty":-8.999358,"median":-1.690757,"eighty":-0.390756,"marketCap":132327560},{"date":"2021-02-26","current":-1.922227,"twenty":-8.999358,"median":-1.702965,"eighty":-0.394019,"marketCap":107644697},{"date":"2021-03-05","current":-1.726331,"twenty":-9.012762,"median":-1.708011,"eighty":-0.398964,"marketCap":96674535},{"date":"2021-03-12","current":-1.93447,"twenty":-9.012762,"median":-1.713344,"eighty":-0.417384,"marketCap":108330332},{"date":"2021-03-19","current":-11.778121,"twenty":-9.090068,"median":-1.721316,"eighty":-0.425301,"marketCap":113635312},{"date":"2021-03-26","current":-10.370673,"twenty":-9.262565,"median":-1.726331,"eighty":-0.431382,"marketCap":100056249},{"date":"2021-04-01","current":-10.592901,"twenty":-9.374401,"median":-1.733316,"eighty":-0.444333,"marketCap":102200311},{"date":"2021-04-09","current":-10.444749,"twenty":-9.925866,"median":-1.740656,"eighty":-0.48054,"marketCap":100770936},{"date":"2021-04-16","current":-8.889148,"twenty":-9.925866,"median":-1.748835,"eighty":-0.509659,"marketCap":85762498},{"date":"2021-04-23","current":-9.370644,"twenty":-9.925866,"median":-1.753802,"eighty":-0.553349,"marketCap":90407971},{"date":"2021-04-30","current":-8.740995,"twenty":-9.925866,"median":-1.759589,"eighty":-0.587693,"marketCap":84333124},{"date":"2021-05-07","current":-13.335277,"twenty":-10.091742,"median":-1.770107,"eighty":-0.738666,"marketCap":128658753},{"date":"2021-05-14","current":-11.415805,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":110139689},{"date":"2021-05-21","current":-10.781942,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":112089064},{"date":"2021-05-28","current":-10.594429,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":110139689},{"date":"2021-06-04","current":-11.438233,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":118911874},{"date":"2021-06-11","current":-11.719502,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":121835943},{"date":"2021-06-18","current":-12.188282,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":126709379},{"date":"2021-06-25","current":-12.657062,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":131582815},{"date":"2021-07-02","current":-11.250721,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":116962499},{"date":"2021-07-09","current":-11.203843,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":116475156},{"date":"2021-07-16","current":-10.406918,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":108190315},{"date":"2021-07-23","current":-10.688185,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":111114376},{"date":"2021-07-30","current":-10.875697,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":113063751},{"date":"2021-08-06","current":-10.12565,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":105266253},{"date":"2021-08-13","current":-9.656869,"twenty":-10.019253,"median":-1.770107,"eighty":-0.744295,"marketCap":100392809},{"date":"2021-08-20","current":-9.272349,"twenty":-9.866745,"median":-1.770107,"eighty":-0.744295,"marketCap":99418122},{"date":"2021-08-27","current":-10.545024,"twenty":-9.757588,"median":-1.770107,"eighty":-0.744295,"marketCap":113063751},{"date":"2021-09-03","current":-10.363214,"twenty":-9.757588,"median":-1.770107,"eighty":-0.744295,"marketCap":111114376},{"date":"2021-09-10","current":-9.908687,"twenty":-9.757588,"median":-1.770107,"eighty":-0.744295,"marketCap":106240941},{"date":"2021-09-17","current":-9.545065,"twenty":-9.64851,"median":-1.770107,"eighty":-0.744295,"marketCap":102342192},{"date":"2021-09-24","current":-9.363254,"twenty":-9.602882,"median":-1.770107,"eighty":-0.744295,"marketCap":100392809},{"date":"2021-10-01","current":-9.272349,"twenty":-9.545065,"median":-1.770107,"eighty":-0.744295,"marketCap":99418122},{"date":"2021-10-08","current":-8.636011,"twenty":-9.367688,"median":-1.770107,"eighty":-0.744295,"marketCap":92595312},{"date":"2021-10-15","current":-8.547833,"twenty":-9.333606,"median":-1.770107,"eighty":-0.744295,"marketCap":91649866},{"date":"2021-10-22","current":-8.710554,"twenty":-9.272349,"median":-1.770107,"eighty":-0.744295,"marketCap":93394556},{"date":"2021-10-29","current":-8.110578,"twenty":-9.260106,"median":-1.770107,"eighty":-0.744295,"marketCap":86961620},{"date":"2021-11-05","current":-8.600558,"twenty":-9.171749,"median":-1.770107,"eighty":-0.745161,"marketCap":92215184},{"date":"2021-11-12","current":-8.254209,"twenty":-9.090068,"median":-1.770107,"eighty":-0.745161,"marketCap":88501626},{"date":"2021-11-19","current":-6.664252,"twenty":-8.945494,"median":-1.770107,"eighty":-0.745161,"marketCap":79924371},{"date":"2021-11-26","current":-7.88251,"twenty":-8.908182,"median":-1.770107,"eighty":-0.745161,"marketCap":94534940},{"date":"2021-12-03","current":-5.810903,"twenty":-8.840366,"median":-1.770107,"eighty":-0.745161,"marketCap":69690156},{"date":"2021-12-10","current":-5.851538,"twenty":-8.798268,"median":-1.770107,"eighty":-0.745161,"marketCap":70177499},{"date":"2021-12-17","current":-5.988887,"twenty":-8.660737,"median":-1.770107,"eighty":-0.745161,"marketCap":71824721},{"date":"2021-12-23","current":-5.89705,"twenty":-8.636011,"median":-1.770107,"eighty":-0.745161,"marketCap":70723324},{"date":"2021-12-31","current":-5.282639,"twenty":-8.601301,"median":-1.770107,"eighty":-0.745161,"marketCap":63354689},{"date":"2022-01-07","current":-4.832395,"twenty":-8.551546,"median":-1.770107,"eighty":-0.746027,"marketCap":57954914},{"date":"2022-01-14","current":-4.876282,"twenty":-8.441289,"median":-1.770107,"eighty":-0.746027,"marketCap":58481245},{"date":"2022-01-21","current":-4.307374,"twenty":-8.437358,"median":-1.770107,"eighty":-0.746027,"marketCap":51658338},{"date":"2022-01-28","current":-4.14484,"twenty":-8.3231,"median":-1.770107,"eighty":-0.746027,"marketCap":49709061},{"date":"2022-02-04","current":-4.5195,"twenty":-8.187347,"median":-1.770107,"eighty":-0.746027,"marketCap":54202369},{"date":"2022-02-11","current":-4.509748,"twenty":-8.1073,"median":-1.770107,"eighty":-0.746027,"marketCap":54085406},{"date":"2022-02-18","current":-4.2318,"twenty":-7.87895,"median":-1.770107,"eighty":-0.746027,"marketCap":50751976},{"date":"2022-02-25","current":-4.367523,"twenty":-7.636811,"median":-1.770107,"eighty":-0.746027,"marketCap":52379704},{"date":"2022-03-04","current":-4.146465,"twenty":-7.156757,"median":-1.770107,"eighty":-0.746027,"marketCap":49728555},{"date":"2022-03-11","current":-4.143214,"twenty":-6.788435,"median":-1.770107,"eighty":-0.746027,"marketCap":49689567},{"date":"2022-03-18","current":-4.632468,"twenty":-6.307308,"median":-1.770107,"eighty":-0.746027,"marketCap":55557184},{"date":"2022-03-25","current":-4.067783,"twenty":-5.991813,"median":-1.770107,"eighty":-0.746027,"marketCap":57701496},{"date":"2022-04-01","current":-3.641765,"twenty":-5.818705,"median":-1.770107,"eighty":-0.746027,"marketCap":51658435},{"date":"2022-04-08","current":-3.538696,"twenty":-5.697123,"median":-1.770107,"eighty":-0.746027,"marketCap":50196404},{"date":"2022-04-14","current":-3.676121,"twenty":-5.518362,"median":-1.770107,"eighty":-0.746027,"marketCap":52145779},{"date":"2022-04-22","current":-3.520144,"twenty":-5.42103,"median":-1.770107,"eighty":-0.746027,"marketCap":49933239},{"date":"2022-04-29","current":-3.22949,"twenty":-5.325924,"median":-1.770107,"eighty":-0.746027,"marketCap":45810312},{"date":"2022-05-06","current":-2.923808,"twenty":-5.287882,"median":-1.770107,"eighty":-0.746027,"marketCap":41474221},{"date":"2022-05-13","current":-2.525906,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":39543066},{"date":"2022-05-20","current":-2.365897,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":37038120},{"date":"2022-05-27","current":-2.618052,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":40985611},{"date":"2022-06-03","current":-2.720782,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":42593845},{"date":"2022-06-10","current":-2.545207,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":39845219},{"date":"2022-06-17","current":-2.4431,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":38246732},{"date":"2022-06-24","current":-2.365897,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":37038120},{"date":"2022-07-01","current":-2.459288,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":38500150},{"date":"2022-07-08","current":-2.60311,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":40751686},{"date":"2022-07-15","current":-2.692142,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":42145489},{"date":"2022-07-22","current":-2.547075,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39874459},{"date":"2022-07-29","current":-2.499751,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39133600},{"date":"2022-08-05","current":-2.521548,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39474838},{"date":"2022-08-12","current":-2.891376,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":45264487},{"date":"2022-08-19","current":-1.131879,"twenty":-5.284265,"median":-1.766483,"eighty":-0.745161,"marketCap":41044193},{"date":"2022-08-26","current":-1.110107,"twenty":-5.284265,"median":-1.756669,"eighty":-0.745161,"marketCap":40254686},{"date":"2022-09-02","current":-1.00716,"twenty":-5.284265,"median":-1.750818,"eighty":-0.745161,"marketCap":36521625},{"date":"2022-09-09","current":-0.968991,"twenty":-5.228721,"median":-1.743495,"eighty":-0.745161,"marketCap":35137566},{"date":"2022-09-16","current":-0.967647,"twenty":-5.13305,"median":-1.739973,"eighty":-0.745161,"marketCap":35088832},{"date":"2022-09-23","current":-0.736756,"twenty":-5.09904,"median":-1.727763,"eighty":-0.74024,"marketCap":26716248},{"date":"2022-09-30","current":-0.782182,"twenty":-5.015848,"median":-1.721316,"eighty":-0.736481,"marketCap":28363474},{"date":"2022-10-07","current":-0.661226,"twenty":-4.934088,"median":-1.717614,"eighty":-0.709858,"marketCap":23977371},{"date":"2022-10-14","current":-0.533102,"twenty":-4.871021,"median":-1.708422,"eighty":-0.608522,"marketCap":19331342},{"date":"2022-10-21","current":-0.499503,"twenty":-4.844354,"median":-1.702965,"eighty":-0.572654,"marketCap":18112980},{"date":"2022-10-28","current":-0.503983,"twenty":-4.837518,"median":-1.692615,"eighty":-0.553005,"marketCap":18275429},{"date":"2022-11-04","current":-0.535342,"twenty":-4.759309,"median":-1.689081,"eighty":-0.549229,"marketCap":19412567},{"date":"2022-11-11","current":-0.678697,"twenty":-4.655621,"median":-1.678549,"eighty":-0.549229,"marketCap":24610911},{"date":"2022-11-18","current":-0.627521,"twenty":-4.629055,"median":-1.678549,"eighty":-0.549229,"marketCap":23858990},{"date":"2022-11-25","current":-0.554703,"twenty":-4.611354,"median":-1.669741,"eighty":-0.549229,"marketCap":21090370},{"date":"2022-12-02","current":-0.586829,"twenty":-4.596503,"median":-1.665114,"eighty":-0.549229,"marketCap":22311820},{"date":"2022-12-09","current":-0.582545,"twenty":-4.592482,"median":-1.658695,"eighty":-0.549229,"marketCap":22148960},{"date":"2022-12-16","current":-0.509727,"twenty":-4.592482,"median":-1.655494,"eighty":-0.543406,"marketCap":19380340},{"date":"2022-12-23","current":-0.421917,"twenty":-4.592482,"median":-1.647648,"eighty":-0.525653,"marketCap":16041710},{"date":"2022-12-30","current":-0.417634,"twenty":-4.592482,"median":-1.638904,"eighty":-0.509727,"marketCap":15878850},{"date":"2023-01-06","current":-0.454043,"twenty":-4.592482,"median":-1.626342,"eighty":-0.498187,"marketCap":17263160},{"date":"2023-01-13","current":-0.458326,"twenty":-4.592482,"median":-1.618166,"eighty":-0.48335,"marketCap":17426020},{"date":"2023-01-20","current":-0.492594,"twenty":-4.592482,"median":-1.617511,"eighty":-0.48335,"marketCap":18728900},{"date":"2023-01-27","current":-0.580404,"twenty":-4.592482,"median":-1.591892,"eighty":-0.48335,"marketCap":22067530},{"date":"2023-02-03","current":-0.674639,"twenty":-4.592482,"median":-1.591653,"eighty":-0.48335,"marketCap":25650450},{"date":"2023-02-10","current":-0.580404,"twenty":-4.592482,"median":-1.583731,"eighty":-0.48335,"marketCap":22067530},{"date":"2023-02-17","current":-0.477602,"twenty":-4.592482,"median":-1.583731,"eighty":-0.480688,"marketCap":18158890},{"date":"2023-02-24","current":-0.406925,"twenty":-4.592482,"median":-1.583517,"eighty":-0.470748,"marketCap":15471700},{"date":"2023-03-03","current":-0.454043,"twenty":-4.592482,"median":-1.583517,"eighty":-0.460896,"marketCap":17263160},{"date":"2023-03-10","current":-0.417334,"twenty":-4.592482,"median":-1.583517,"eighty":-0.450652,"marketCap":15867449},{"date":"2023-03-17","current":-0.396217,"twenty":-4.592482,"median":-1.569527,"eighty":-0.448315,"marketCap":15064550},{"date":"2023-03-24","current":-0.399429,"twenty":-4.564687,"median":-1.562425,"eighty":-0.444619,"marketCap":15186695},{"date":"2023-03-31","current":-0.417246,"twenty":-4.519825,"median":-1.552061,"eighty":-0.438651,"marketCap":16204570},{"date":"2023-04-06","current":-0.406779,"twenty":-4.509911,"median":-1.541119,"eighty":-0.432034,"marketCap":15798064},{"date":"2023-04-14","current":-0.526296,"twenty":-4.398569,"median":-1.526915,"eighty":-0.430228,"marketCap":20439763},{"date":"2023-04-21","current":-0.620848,"twenty":-4.283651,"median":-1.505609,"eighty":-0.430228,"marketCap":24111882},{"date":"2023-04-28","current":-0.654903,"twenty":-4.151991,"median":-1.491697,"eighty":-0.430228,"marketCap":25434475},{"date":"2023-05-05","current":-0.662762,"twenty":-4.089087,"median":-1.477202,"eighty":-0.430228,"marketCap":25739688},{"date":"2023-05-12","current":-0.705671,"twenty":-4.070648,"median":-1.462998,"eighty":-0.432544,"marketCap":27406155},{"date":"2023-05-19","current":-0.587667,"twenty":-4.070648,"median":-1.462998,"eighty":-0.439616,"marketCap":23399717},{"date":"2023-05-26","current":-0.569781,"twenty":-4.070648,"median":-1.462998,"eighty":-0.447562,"marketCap":22687551},{"date":"2023-06-02","current":-0.569781,"twenty":-4.070648,"median":-1.462998,"eighty":-0.449009,"marketCap":22687551},{"date":"2023-06-09","current":-0.674539,"twenty":-4.070648,"median":-1.462998,"eighty":-0.451486,"marketCap":26858805},{"date":"2023-06-16","current":-0.666874,"twenty":-4.070648,"median":-1.462998,"eighty":-0.460896,"marketCap":26553591},{"date":"2023-06-23","current":-0.648989,"twenty":-4.072081,"median":-1.462998,"eighty":-0.470534,"marketCap":25841426},{"date":"2023-06-30","current":-0.628548,"twenty":-4.073513,"median":-1.462998,"eighty":-0.479792,"marketCap":25027523},{"date":"2023-07-07","current":-0.613218,"twenty":-4.074946,"median":-1.466549,"eighty":-0.487594,"marketCap":24417096},{"date":"2023-07-14","current":-0.664319,"twenty":-4.074946,"median":-1.466549,"eighty":-0.496877,"marketCap":26451854},{"date":"2023-07-21","current":-0.697535,"twenty":-4.074946,"median":-1.466549,"eighty":-0.503983,"marketCap":27774446},{"date":"2023-07-28","current":-0.643878,"twenty":-4.074946,"median":-1.466549,"eighty":-0.518294,"marketCap":25637950},{"date":"2023-08-04","current":-0.682205,"twenty":-4.074946,"median":-1.466549,"eighty":-0.526861,"marketCap":27164019},{"date":"2023-08-11","current":-0.753747,"twenty":-4.074946,"median":-1.466549,"eighty":-0.535342,"marketCap":30012680},{"date":"2023-08-18","current":-1.425454,"twenty":-4.074946,"median":-1.480753,"eighty":-0.551021,"marketCap":27876184},{"date":"2023-08-25","current":-1.461871,"twenty":-4.074946,"median":-1.486093,"eighty":-0.554703,"marketCap":28588349},{"date":"2023-09-01","current":-1.560716,"twenty":-4.074946,"median":-1.497084,"eighty":-0.559981,"marketCap":30521370},{"date":"2023-09-08","current":-1.123716,"twenty":-4.074946,"median":-1.497084,"eighty":-0.567553,"marketCap":21975386},{"date":"2023-09-15","current":-1.061287,"twenty":-4.074946,"median":-1.497084,"eighty":-0.569781,"marketCap":20754531},{"date":"2023-09-22","current":-1.030073,"twenty":-4.074946,"median":-1.497084,"eighty":-0.577447,"marketCap":20144104},{"date":"2023-09-29","current":-1.014466,"twenty":-4.074946,"median":-1.497084,"eighty":-0.580404,"marketCap":19838890},{"date":"2023-10-06","current":-1.061287,"twenty":-4.074946,"median":-1.497084,"eighty":-0.586829,"marketCap":20754531},{"date":"2023-10-13","current":-0.978049,"twenty":-4.074946,"median":-1.497084,"eighty":-0.591112,"marketCap":19126725},{"date":"2023-10-20","current":-0.874001,"twenty":-4.074946,"median":-1.497084,"eighty":-0.598008,"marketCap":17091967},{"date":"2023-10-27","current":-0.879204,"twenty":-4.074946,"median":-1.498288,"eighty":-0.60429,"marketCap":17193705},{"date":"2023-11-03","current":-0.926025,"twenty":-4.074946,"median":-1.498288,"eighty":-0.611179,"marketCap":18109346},{"date":"2023-11-10","current":-0.93643,"twenty":-4.074946,"median":-1.498288,"eighty":-0.61571,"marketCap":18312822},{"date":"2023-11-17","current":-0.886346,"twenty":-4.074946,"median":-1.498288,"eighty":-0.619712,"marketCap":15972850},{"date":"2023-11-24","current":-0.824246,"twenty":-4.074946,"median":-1.498288,"eighty":-0.625361,"marketCap":14853733},{"date":"2023-12-01","current":-1.072649,"twenty":-4.074946,"median":-1.498288,"eighty":-0.631103,"marketCap":19330201},{"date":"2023-12-08","current":-1.001515,"twenty":-4.074946,"median":-1.4999,"eighty":-0.637045,"marketCap":18048303},{"date":"2023-12-14","current":-1.016193,"twenty":-4.079822,"median":-1.505609,"eighty":-0.642299,"marketCap":18312822},{"date":"2023-12-22","current":-1.067003,"twenty":-4.087137,"median":-1.505609,"eighty":-0.646797,"marketCap":19228463},{"date":"2023-12-29","current":-0.987966,"twenty":-4.088112,"median":-1.505609,"eighty":-0.649529,"marketCap":17804132},{"date":"2024-01-05","current":-1.010548,"twenty":-4.089087,"median":-1.507151,"eighty":-0.654231,"marketCap":18211084},{"date":"2024-01-12","current":-0.959738,"twenty":-4.089087,"median":-1.507151,"eighty":-0.659769,"marketCap":17295443},{"date":"2024-01-19","current":-0.886346,"twenty":-4.090063,"median":-1.501511,"eighty":-0.660576,"marketCap":15972850},{"date":"2024-01-26","current":-0.897638,"twenty":-4.089087,"median":-1.491551,"eighty":-0.660792,"marketCap":16176326},{"date":"2024-02-02","current":-0.92022,"twenty":-4.089087,"median":-1.480753,"eighty":-0.660792,"marketCap":16583277},{"date":"2024-02-09","current":-0.846828,"twenty":-4.089087,"median":-1.46264,"eighty":-0.660792,"marketCap":15260685},{"date":"2024-02-16","current":-0.86941,"twenty":-4.089087,"median":-1.451384,"eighty":-0.660792,"marketCap":15667636},{"date":"2024-02-23","current":-0.8186,"twenty":-4.089087,"median":-1.439402,"eighty":-0.660792,"marketCap":14751995},{"date":"2024-03-01","current":-0.807309,"twenty":-4.088112,"median":-1.429101,"eighty":-0.661009,"marketCap":14548519},{"date":"2024-03-08","current":-0.829891,"twenty":-4.088112,"median":-1.419929,"eighty":-0.661009,"marketCap":14955471},{"date":"2024-03-15","current":-0.829044,"twenty":-4.088112,"median":-1.403373,"eighty":-0.661009,"marketCap":14940210},{"date":"2024-03-22","current":-0.852473,"twenty":-4.088112,"median":-1.369036,"eighty":-0.661009,"marketCap":15362422},{"date":"2024-03-28","current":-0.846828,"twenty":-4.088112,"median":-1.3397,"eighty":-0.661009,"marketCap":15260685},{"date":"2024-04-05","current":-0.831599,"twenty":-4.089087,"median":-1.30291,"eighty":-0.660792,"marketCap":14955471},{"date":"2024-04-12","current":-0.876856,"twenty":-4.089087,"median":-1.294681,"eighty":-0.660792,"marketCap":15769374},{"date":"2024-04-19","current":-0.845742,"twenty":-4.089087,"median":-1.277663,"eighty":-0.660792,"marketCap":15209816},{"date":"2024-04-26","current":-0.854227,"twenty":-4.088112,"median":-1.273457,"eighty":-0.661009,"marketCap":15362422},{"date":"2024-05-03","current":-0.899484,"twenty":-4.088112,"median":-1.227471,"eighty":-0.661009,"marketCap":16176326},{"date":"2024-05-10","current":-0.989998,"twenty":-4.088112,"median":-1.204981,"eighty":-0.661009,"marketCap":17804132},{"date":"2024-05-17","current":-1.193451,"twenty":-4.088112,"median":-1.192088,"eighty":-0.661009,"marketCap":19991497},{"date":"2024-05-24","current":-1.257223,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":21059745},{"date":"2024-05-31","current":-1.433356,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":24010144},{"date":"2024-06-07","current":-1.567035,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":26249395},{"date":"2024-06-14","current":-1.585255,"twenty":-4.089087,"median":-1.177345,"eighty":-0.660792,"marketCap":26554609},{"date":"2024-06-21","current":-1.548753,"twenty":-4.090063,"median":-1.177036,"eighty":-0.660576,"marketCap":25943164},{"date":"2024-06-28","current":-1.548753,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":25943164},{"date":"2024-07-05","current":-1.396915,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":23399717},{"date":"2024-07-12","current":-1.330106,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":22280600},{"date":"2024-07-15","current":-1.396915,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":23399717},{"date":"2024-08-02","current":-1.178267,"twenty":-4.144515,"median":-1.153973,"eighty":-0.656828,"marketCap":19737152},{"date":"2024-08-09","current":-1.026429,"twenty":-4.144515,"median":-1.145075,"eighty":-0.656828,"marketCap":17193705},{"date":"2024-08-16","current":-0.970392,"twenty":-4.144515,"median":-1.127576,"eighty":-0.656828,"marketCap":17397180},{"date":"2024-08-23","current":-1.072538,"twenty":-4.144515,"median":-1.122776,"eighty":-0.656828,"marketCap":19228463},{"date":"2024-08-30","current":-0.959042,"twenty":-4.144515,"median":-1.119642,"eighty":-0.656828,"marketCap":17193705},{"date":"2024-09-06","current":-1.01579,"twenty":-4.144515,"median":-1.114787,"eighty":-0.656828,"marketCap":18211084},{"date":"2024-09-13","current":-0.953367,"twenty":-4.144515,"median":-1.108915,"eighty":-0.656828,"marketCap":17091967},{"date":"2024-09-20","current":-0.998766,"twenty":-4.144515,"median":-1.096861,"eighty":-0.656828,"marketCap":17905870},{"date":"2024-09-27","current":-0.970392,"twenty":-4.144515,"median":-1.08975,"eighty":-0.656828,"marketCap":17397180},{"date":"2024-10-04","current":-0.981741,"twenty":-4.144515,"median":-1.088446,"eighty":-0.656828,"marketCap":17600656},{"date":"2024-10-11","current":-0.993091,"twenty":-4.144515,"median":-1.083888,"eighty":-0.656828,"marketCap":17804132},{"date":"2024-10-18","current":-1.15766,"twenty":-4.144515,"median":-1.086013,"eighty":-0.656828,"marketCap":20754531},{"date":"2024-10-25","current":-1.106587,"twenty":-4.144515,"median":-1.089629,"eighty":-0.656828,"marketCap":19838890},{"date":"2024-10-31","current":-1.02714,"twenty":-4.144515,"median":-1.089629,"eighty":-0.656828,"marketCap":18414559},{"date":"2024-11-08","current":-0.964717,"twenty":-4.14484,"median":-1.089689,"eighty":-0.662762,"marketCap":17295443},{"date":"2024-11-15","current":-1.196788,"twenty":-4.14484,"median":-1.090583,"eighty":-0.665382,"marketCap":22382338},{"date":"2024-11-22","current":-1.169589,"twenty":-4.14484,"median":-1.096861,"eighty":-0.670621,"marketCap":21873648},{"date":"2024-11-29","current":-1.123621,"twenty":-4.14484,"median":-1.107348,"eighty":-0.674539,"marketCap":21013963},{"date":"2024-12-06","current":-1.02271,"twenty":-4.14484,"median":-1.108975,"eighty":-0.679649,"marketCap":19126725},{"date":"2024-12-13","current":-1.01183,"twenty":-4.14484,"median":-1.108975,"eighty":-0.687315,"marketCap":18923249},{"date":"2024-12-20","current":-1.142389,"twenty":-4.14484,"median":-1.110783,"eighty":-0.697513,"marketCap":21364959},{"date":"2024-12-27","current":-1.349107,"twenty":-4.14484,"median":-1.115045,"eighty":-0.705671,"marketCap":25230999},{"date":"2025-01-03","current":-1.262068,"twenty":-4.14484,"median":-1.118187,"eighty":-0.725736,"marketCap":23603192},{"date":"2025-01-10","current":-1.309395,"twenty":-4.145165,"median":-1.120629,"eighty":-0.741734,"marketCap":24488312},{"date":"2025-01-17","current":-1.093429,"twenty":-4.145165,"median":-1.122656,"eighty":-0.761253,"marketCap":20449317},{"date":"2025-01-24","current":-1.133685,"twenty":-4.145165,"median":-1.122776,"eighty":-0.774604,"marketCap":21202178},{"date":"2025-01-31","current":-1.083638,"twenty":-4.145165,"median":-1.122776,"eighty":-0.784117,"marketCap":20266189},{"date":"2025-02-07","current":-1.02815,"twenty":-4.145165,"median":-1.122776,"eighty":-0.795815,"marketCap":19228463},{"date":"2025-02-14","current":-1.01183,"twenty":-4.145165,"median":-1.123621,"eighty":-0.808638,"marketCap":18923249},{"date":"2025-02-21","current":-1.06623,"twenty":-4.145165,"median":-1.123621,"eighty":-0.817765,"marketCap":19940628},{"date":"2025-02-28","current":-0.941111,"twenty":-4.145165,"median":-1.122776,"eighty":-0.818532,"marketCap":17600656},{"date":"2025-03-07","current":-0.957431,"twenty":-4.14549,"median":-1.120629,"eighty":-0.818465,"marketCap":17905870},{"date":"2025-03-14","current":-0.908471,"twenty":-4.14549,"median":-1.11932,"eighty":-0.818465,"marketCap":16990229},{"date":"2025-03-21","current":-0.843192,"twenty":-4.14549,"median":-1.11932,"eighty":-0.820967,"marketCap":15769374},{"date":"2025-03-28","current":-0.777912,"twenty":-4.14549,"median":-1.11932,"eighty":-0.820967,"marketCap":14548519},{"date":"2025-04-04","current":-0.819529,"twenty":-4.14549,"median":-1.11932,"eighty":-0.824246,"marketCap":14345043},{"date":"2025-04-11","current":-0.712003,"twenty":-4.145165,"median":-1.118997,"eighty":-0.821195,"marketCap":12462892},{"date":"2025-04-17","current":-0.761407,"twenty":-4.145165,"median":-1.118437,"eighty":-0.81871,"marketCap":13327664},{"date":"2025-04-25","current":-0.848591,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":14853733},{"date":"2025-05-02","current":-0.918338,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":16074588},{"date":"2025-05-09","current":-0.911479,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":15954537},{"date":"2025-05-16","current":-0.836966,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":14650257},{"date":"2025-05-23","current":-0.937203,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":14853733},{"date":"2025-05-30","current":-0.998186,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":15820243},{"date":"2025-06-06","current":-1.04633,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":16583277},{"date":"2025-06-13","current":-0.988557,"twenty":-4.14549,"median":-1.117919,"eighty":-0.815906,"marketCap":15667636},{"date":"2025-06-20","current":-0.994976,"twenty":-4.145815,"median":-1.111458,"eighty":-0.815863,"marketCap":15769374},{"date":"2025-06-27","current":-0.994976,"twenty":-4.145815,"median":-1.106587,"eighty":-0.815863,"marketCap":15769374},{"date":"2025-07-03","current":-0.975718,"twenty":-4.145815,"median":-1.097683,"eighty":-0.815863,"marketCap":15464160},{"date":"2025-07-11","current":-1.007814,"twenty":-4.145815,"median":-1.093429,"eighty":-0.815863,"marketCap":15972850},{"date":"2025-07-18","current":-1.084845,"twenty":-4.145815,"median":-1.091415,"eighty":-0.815863,"marketCap":17193705},{"date":"2025-07-25","current":-1.03991,"twenty":-4.145815,"median":-1.088446,"eighty":-0.815863,"marketCap":16481539},{"date":"2025-08-01","current":-1.110522,"twenty":-4.145815,"median":-1.08799,"eighty":-0.815863,"marketCap":17600656},{"date":"2025-08-04","current":-1.187552,"twenty":-4.145815,"median":-1.08799,"eighty":-0.815863,"marketCap":18821511}],"updateTime":1754418310407}}}